Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
World Asset Management Inc increased its holdings in DexCom, Inc. (NASDAQ:DXCM) by 18.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange C
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia

4 Must-Own Recession Stocks | The Motley Fool

11:21am, Sunday, 26'th Jul 2020
Forget running and hiding: A recession is the perfect time to buy into these dominant companies.
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
Symmetry Partners LLC bought a new stake in DexCom, Inc. (NASDAQ:DXCM) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fir
Raymond James Financial Services Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM) by 59.0% in the second quarter, according to its most recent filing with the SEC. The fund
The diabetes-care leader still has tremendous growth prospects.
It's been quite entertaining lately to watch the Americans waddle around whinging about how oppressed they are, when it's apparent that none of them have ever visited an actual dictatorship. In many o
Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM) in the second quarter, according to its most recent Form 13F filing with the Securit

Is Dexcom Stock a Buy? | The Motley Fool

11:19am, Thursday, 16'th Jul 2020
The company is having a good year on the stock market, but how long can that last?
DexCom, Inc. (NASDAQ:DXCM) SVP Shelly Ramasamy Selvaraj sold 400 shares of the business’s stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $439.33, for a tot
Independent clinical evaluations indicate that elevated blood lactic acid level is an indicator for disease progression in Covid-19.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE